NS · Pharmaceuticals

Jubilant Pharmova Ltd (JUBLPHARMA)

Pharmaceuticals & Biotechnology

Jubilant Pharmova Ltd (JUBLPHARMA) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $155.80B, P/E ratio is 246.39, net margin is 9.9%, dividend yield is 0.51%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for JUBLPHARMA

Market cap

$155.80B

P/E ratio

246.39

Net margin

9.9%

Dividend yield

0.51%

Jubilant Pharmova Ltd (JUBLPHARMA) — FAQ

What is Jubilant Pharmova Ltd's market cap?

Jubilant Pharmova Ltd (JUBLPHARMA) has a reported market cap of $155.80B (data as of 2026-07-10).

What is JUBLPHARMA's P/E ratio?

The price-to-earnings (P/E) ratio for Jubilant Pharmova Ltd (JUBLPHARMA) is 246.39 (data as of 2026-07-10).

Does Jubilant Pharmova Ltd pay a dividend?

Jubilant Pharmova Ltd (JUBLPHARMA) shows a reported dividend yield of 0.51%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Jubilant Pharmova Ltd in?

Jubilant Pharmova Ltd (JUBLPHARMA) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is JUBLPHARMA listed on?

JUBLPHARMA is listed on NS.

What is Jubilant Pharmova Ltd's net margin?

Jubilant Pharmova Ltd (JUBLPHARMA) reports a net margin of 9.9% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)